ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
11.18
-0.14 (-1.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.09 billion as of December 20, 2024. Its market cap has increased by 116.83% in one year.
Market Cap
1.09B
Enterprise Value
881.82M
1-Year Change
116.83%
Ranking
Category
Stock Price
$11.18
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.09B, an increase of 91.21%. That is a compound annual growth rate of 35.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.09B | 106.54% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Weave Communications | 1.14B |
| Innoviva | 1.12B |
| Enliven Therapeutics | 1.12B |
| Ardelyx | 1.11B |
| CareDx | 1.10B |
| Syndax Pharmaceuticals | 1.10B |
| Pulse Biosciences | 1.09B |
| Establishment Labs Holdings | 1.09B |